Pharmaceuticals and Biotech

Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announces two senior hires to boost its platform and expand its strategic life science partnerships.Today, Asif Jan and Sezai Taskin bring the Owkin team an…

As an industry leader in global alignment, MedEvoke is positioned to offer unique, scientifically compelling narratives and digitally oriented solutions to overcome the ever-changing needs of Medical Affairs and Clinical Trials professionals. Today, MedEvoke is excited to announce the addition…

Current Adoption Status: 67 collection protocols / 40+ active usersPublished 67 peer-reviewed articlesSupported 20 grantsManages 400K specimens for 40K study participants100+K specimens sent to Precision Medicine platform*Reference: 2019 OpenSpecimen JHU Annual ReportThe Johns Hopkins University School of Medicine adopted OpenSpecimen…

Climet Instruments Company, a Division of Venturedyne Ltd, (herein 'Climet') the leading manufacturer of high quality cleanroom particle counters and microbial samplers, today announced the introduction of their CI-97 microbial air sampler.Climet Instruments Company is very proud to announce the introduction of the…

EW Healthcare Partners ("EW") has acquired a majority stake in Laboratoires Majorelle ("Majorelle") from its Founders to support its growth and European expansion in line with the Founders' strategy.Headquartered in Paris, Majorelle is a French specialty pharma company focused on…

Americans have been hearing about forthcoming changes to the pharmaceutical industry that will work to lower the prices for prescription drugs for years now. There's been little in the way of progress there. There are a host of reasons why…

WholisticResearch, the fact-finding blog on rare nootropics and peptides, announced today that it had acquired the domain name previously owned by Adherex Technologies Inc. biopharmaceutical company, committed to discover and develop therapeutics for cancer and cognitive improvement.The CEO of WholisticResearch shared, "I…

GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals ("RB&H"), recently merged with Guy's and St Thomas' NHS Foundation Trust ("GSTT"),…

Investment and growth firm Valkyrie Group ("Valkyrie") has committed an investment of $25 million into Aneira Pharma, Inc. ("Aneira") to be used toward completion of its clinical trials. Aneira is developing a ground-breaking, prescription-based hair growth product for men and…

Today, Ottobock and its Board of Directors announced the appointment of Marc C. Lundeberg as the new CEO and Regional President of the company's North America operation. Effective February 1, 2021, Marc succeeds Brad Ruhl, who will remain on as…

Adversity has a way of bringing out the best in people, and that has certainly been the case for the hard-working teams of experts who represent OPTEL GROUP in the Asia-Pacific region.OPTEL, a world leader in pharmaceutical track and trace…

CapsCanada, a Lyfe Group™ company and leader in capsule technology for over three decades, is pleased to announce the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada's objective is to support the entire manufacturing process, from formulation and…

On this Triple Negative Breast Cancer awareness day, Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule targeted anticancer agent tumor sensitizing technology, announced the publication of new research findings in PLOS…

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, announces the lead compound AKE-1018 significantly reduces neuropathic pain in preclinical testing.Akelos's oral lead compound AKE-1018, at 10-times the lowest…

Enterin, Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative diseases, announces that the company will be presenting at Chardan's virtual 3rd Annual Microbiome Medicines Summit on March 8, 2021, at 8:30 a.m. ET.Dr. Denise Barbut, Enterin's…

RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new antibody discovery platform, Galaxy™, that offers significant advantages over the current generation of tools for delivery of new therapeutic monoclonal antibodies."Monoclonal antibodies make up…

Avexegen Therapeutics Inc. today announced that it has received a Phase 2 award of $2.94 million under the National Institutes of Health's Small Business Innovation Research Program (SBIR) for the development of an oral Neuregulin-4-based therapy for inflammatory bowel disease…

Polaryx Therapeutics, Inc., a biotech company developing small molecule therapeutics for lysosomal storage disorders, announced today that it has received both Rare Pediatric Disease and Orphan Drug Designations for the treatment of Krabbe Disease (a.k.a. Globoid Cell Leukodystrophy) with PLX-300 from the U.S. Food and…

Effectively immediately, Thomas Kutrubes has been removed from privately owned and independent supplier of life science laboratory products — Peak Serum, Inc. (Peak) — by the chief restructuring officer and Trustee, Jay Roderick. Michael Dodge, Peak's current global director of…

Nichol brings years of experience and entrepreneurial success. Nichol is a mother of 3 amazing kids and a widow to her loving late husband of 25 years. At the age of 21 Nichol created her first company with 50 employees.…